![](images/logo.png?v=2)
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 4
July-August 2024
Indexing Partners
![Academia.edu Academia](images/index-partners/academia.png)
![Advanced Sciences Index Advanced Sciences Index](images/index-partners/advanced-sciences.png)
![Bielefeld Academic Search Engine Bielefeld Academic Search Engine](images/index-partners/bielefeld.gif)
![CiteSeer CiteSeer](images/index-partners/cite-seer.png)
![DRJI DRJI](images/index-partners/drji.png)
![Google Scholar Google Scholar](images/index-partners/google-scholar.png)
![Independent Search Engine & Directory Network (isedn.org) Independent Search Engine & Directory Network](images/index-partners/isedn.jpg)
![ISI (International Scientific Indexing) ISI (International Scientific Indexing)](images/index-partners/isi.png)
![Issuu Issuu](images/index-partners/issuu.png)
![Mendeley Research Networks Mendeley Research Networks](images/index-partners/mendeley.png)
![RefSeek RefSeek](images/index-partners/ref-seek.png)
![ResearcherId - Thomson Reuters ResearcherId - Thomson Reuters](images/index-partners/researcher-id.png)
![ResearchGate ResearchGate](images/index-partners/research-gate.png)
![Scirus Scirus](images/index-partners/scirus.png)
![Scribd Scribd](images/index-partners/scribd.gif)
![Semantic Scholar Semantic Scholar](images/index-partners/semantic-scholar.png)
![UTeM - Universiti Teknikal Malaysia Melaka UTeM - Universiti Teknikal Malaysia Melaka](images/index-partners/utem.png)
![Wiki for Call for Papers Wiki for Call for Papers](images/index-partners/wiki-cfp.png)
![WorldCat WorldCat](images/index-partners/world-cat.png)
N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels
Author(s) | Lucky Togihon Harjantho, Suryanti Dwi Pratiwi, Susanthy Djajalaksana, Aditya Sri Listyoko, Harun Al Rasyid |
---|---|
Country | Indonesia |
Abstract | Introduction: Many unique pathologies, such as hyperinflammation and hypercoagulopathy, have been associated with Covid-19, resulting in critical illness and poor outcomes. N-Acetylcysteine (NAC), a precursor of the antioxidant glutathione, has a number of biological effects, including increasing antioxidant capacity, inhibiting viral replication, and suppressing the release of proinflammatory cytokines, such as IL-1????, which further reduces coagulopathy as measured by D-dimer and PADUA scores. The aim of this research is to analyze the effect of NAC as an adjunctive therapy on the level of IL-1????, D-dimer and PADUA scores among Covid-19 patients. Method: A quasi-experimental, non-equivalent group, single-center study included 91 hospitalized confirmed Covid-19 patients by RT-PCR, 75 patients received standard of care plus 5000 mg/72 hours of NAC and 16 patients received standard of care without NAC. On the first and eighth days of treatment, IL-1????, D-dimer levels, and PADUA scores were measured by ELISA and quantitative-assay methods. Data analysis used were Mann-Whitney test, Wilcoxon test, and Spearman-rho correlation test. Result: After the eighth day of therapy, the NAC group had a statistically significantly reduction in IL-1????(pg/mL) (1,48[-4,23-6,68] vs -0,43[-3,40-2,0], p=0.03) and D-dimer(µg/mL) (0,75[-5,98-6,45] vs -0,03[-8,07-1,00], p<0,001) levels than the control group, but not in PADUA scores (1,05[0-3] vs 0,94[0-1], p=0,458). In a subanalysis of NAC's group, IL-1???? was found to be quite strongly correlated with D-dimer (r=0,508, p<0,001). Conclusion: Our findings show that supplementary NAC reduces hyperinflammation and hypercoagulopathy in Covid-19 patients by suppressing IL-1???? and lowering D-dimer, and thus could be used as a supplement to Covid-19 therapy. |
Keywords | COVID-19, N-acetylcysteine, IL-1????, coagulopathy, D-dimer |
Field | Medical / Pharmacy |
Published In | Volume 6, Issue 1, January-February 2024 |
Published On | 2024-02-10 |
Cite This | N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels - Lucky Togihon Harjantho, Suryanti Dwi Pratiwi, Susanthy Djajalaksana, Aditya Sri Listyoko, Harun Al Rasyid - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.5554 |
DOI | https://doi.org/10.36948/ijfmr.2024.v06i01.5554 |
Short DOI | https://doi.org/gthqr9 |
Share this
E-ISSN 2582-2160
![](images/ean-13-barcode.gif)
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
![](images/loading.gif)